Tristel Regulatory News (TSTL)

20 Mar 2007 07:01

Tristel PLC20 March 2007 TRISTEL PLC Grant of Patent Tristel plc ("Tristel"), the AIM listed provider of infection and contaminationcontrol products, announces that it has been granted a patent from the UK PatentOffice for its Chlorine Dioxide Generator, known as the Tristel Generator. The Tristel Generator delivers the company's proprietary chlorine dioxidechemistry, which is highly effective in destroying all types of bacteria(including bacterial spores, tuberculosis and MRSA), fungi and viruses and isone of a small group of sporicidal agents that is safe and easy to use. The Tristel Generator is used to produce a high-level disinfectant forendoscopes and dental unit water lines as well as producing bacteria-free rinsewater for instrument washer-disinfectors. It is also used for biofilmelimination and Legionella control. The Tristel Generator produces a continuoussupply of chlorine dioxide, at concentrations that are set by the user and canbe varied manually irrespective of the water flow. Tristel's core product range of instrument disinfectants has become the marketleader in the UK Acute & Private Hospital sector. They are used to decontaminateheat sensitive endoscopic and ultrasound instruments in over 375 hospitals,representing some 60 per cent. of all UK NHS Acute & Private Hospitals. Contacts: Tristel plc Parkgreen Communications Ltd Paul Swinney Paul McManusChief Executive Tel: 020 7479 7933Tel: 01638 721 500 Mob: 07980 541 893 Email:paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange